Highlights Henry Schein, Inc.

Equities

HSIC

US8064071025

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2026-01-15 pm EST			5-day change	1st Jan Change
78.08 ^USD	+2.39%		-1.16%	+3.31%

Jan. 15	Henry Schein enters distribution agreement for CytoChip's CLIA-waived hematology analyzer	RE
Jan. 15	Henry Schein Agrees to Distribute CytoChip's CitoCBC system	MT

Highlights

Jan. 15	Henry Schein Agrees to Distribute CytoChip's CitoCBC system	MT
Jan. 15	Henry Schein Enters Exclusive Distribution Agreement for CytoChip's CLIA-Waived Hematology Analyzer	CI
Jan. 13	Henry Schein Seeks M&A Opportunities	CI
Dec. 01	Henry Schein Becomes Exclusive US Distributor of vVARDIS' Curodont Treatment in January	MT
Dec. 01	Henry Schein, Inc. Expands Partnership with Vvardis	CI
Nov. 25	Biomerica's inFoods IBS Product Featured in Biotherapeutics Quarterly	CI
Nov. 05	VideaHealth and Henry Schein One Launch the Impact Panel, Bringing AI-Driven Patient Education to Dentrix and Dentrix Ascend	CI
Nov. 04	Tranche Update on Henry Schein, Inc.'s Equity Buyback Plan announced on December 13, 2018.	CI
Nov. 04	Wall St falls after big banks' CEOs warn of market downturn; Palantir slides	RE
Nov. 04	Henry Schein, Inc. Raises Earnings Guidance for the Year 2025	CI
Nov. 04	Henry Schein, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 27, 2025	CI
Nov. 04	Henry Schein lifts annual forecast on strong dental, medical equipment sales	RE
Nov. 04	Henry Schein Q3 Adjusted Earnings, Revenue Rise; 2025 EPS Guidance Raised	MT
Nov. 04	(HSIC) Henry Schein Expects Full Year 2025 Adjusted EPS Range $4.88 to $4.96, vs. FactSet Est of $4.82	MT
Nov. 04	Henry Schein Q3 results beat estimates	RE
Nov. 04	Earnings Flash (HSIC) Henry Schein, Inc. Reports Q3 Revenue $3.34B, vs. FactSet Est of $3.28B	MT
Nov. 04	Earnings Flash (HSIC) Henry Schein, Inc. Posts Q3 Adjusted EPS $1.38 per Share, vs. FactSet Est of $1.28	MT
25-10-16	Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's Infoods®? Ibs Test in the U.S	CI
25-10-16	Biomerica Says Irritable Bowel Syndrome Test to be Marketed by Henry Schein in US	MT
25-09-09	Henry Schein Reports $750 Million Share Repurchase Program	MT
25-09-09	Henry Schein announces $750 million share repurchase plan	RE
25-09-09	Henry Schein Medical Expands SolutionsHub with Colaborate	CI
25-09-08	Henry Schein, Inc. announces an Increase in Equity Buyback.	CI
25-08-05	Tranche Update on Henry Schein, Inc.'s Equity Buyback Plan announced on December 13, 2018.	CI
25-08-05	Sector Update: Health Care Stocks Lean Lower Premarket Tuesday	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Highlights Henry Schein, Inc.

Equities

HSIC

US8064071025

Medical Equipment, Supplies & Distribution

Highlights

Filters